If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,235.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.163%)
Market Cap: £854.61m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Transaction in Own Shares

9 Jan 2026 07:00

RNS Number : 2479O
CVS Group plc
09 January 2026
 

09 January 2026

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 08 January 2026 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

08/01/2026

Aggregate number of Ordinary Shares purchased:

30,898

Lowest price paid per share (GBp):

1,298.00

Highest price paid per share (GBp):

1,326.00

Volume weighted average price paid per share (GBp):

1,310.61

CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 70,581,631 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 70,581,631 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 1,159,152 Ordinary Shares in aggregate at a weighted average price of 1,228.99 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 

66

1322

08/01/2026 08:01:00

1366925565233512

XLON

216

1322

08/01/2026 08:06:18

1366925565234731

XLON

304

1322

08/01/2026 08:06:18

1366925565234744

XLON

1322

1326

08/01/2026 08:12:58

1366925565235644

XLON

625

1326

08/01/2026 08:12:58

1366925565235651

XLON

277

1324

08/01/2026 08:17:17

1366925565236330

XLON

139

1322

08/01/2026 08:29:47

1366925565238411

XLON

99

1320

08/01/2026 08:29:47

1366925565238415

XLON

290

1320

08/01/2026 08:29:47

1366925565238414

XLON

550

1320

08/01/2026 08:31:19

1366925565238691

XLON

962

1318

08/01/2026 08:38:04

1366925565239624

XLON

66

1320

08/01/2026 08:38:09

1366925565239658

XLON

1104

1318

08/01/2026 08:40:03

1366925565239903

XLON

290

1318

08/01/2026 08:40:03

1366925565239905

XLON

20

1318

08/01/2026 08:40:03

1366925565239906

XLON

796

1318

08/01/2026 08:40:03

1366925565239907

XLON

1050

1318

08/01/2026 08:40:44

1366925565240010

XLON

290

1318

08/01/2026 08:40:45

1366925565240011

XLON

805

1318

08/01/2026 08:40:45

1366925565240012

XLON

122

1318

08/01/2026 08:41:08

1366925565240077

XLON

915

1316

08/01/2026 08:49:00

1366925565240863

XLON

327

1316

08/01/2026 08:49:00

1366925565240865

XLON

397

1310

08/01/2026 08:56:44

1366925565241742

XLON

334

1310

08/01/2026 08:56:44

1366925565241745

XLON

425

1310

08/01/2026 09:20:29

1366925565245248

XLON

1

1310

08/01/2026 09:20:29

1366925565245249

XLON

73

1310

08/01/2026 09:20:30

1366925565245256

XLON

66

1310

08/01/2026 09:20:36

1366925565245278

XLON

136

1308

08/01/2026 09:25:52

1366925565245718

XLON

995

1308

08/01/2026 09:25:52

1366925565245721

XLON

974

1306

08/01/2026 09:26:20

1366925565245806

XLON

964

1306

08/01/2026 09:26:20

1366925565245809

XLON

961

1304

08/01/2026 09:27:00

1366925565245903

XLON

103

1304

08/01/2026 09:27:10

1366925565245960

XLON

202

1306

08/01/2026 09:28:58

1366925565246136

XLON

440

1306

08/01/2026 09:28:58

1366925565246137

XLON

116

1308

08/01/2026 09:33:03

1366925565246664

XLON

263

1306

08/01/2026 09:34:18

1366925565246827

XLON

928

1306

08/01/2026 09:34:56

1366925565246848

XLON

914

1308

08/01/2026 09:39:15

1366925565247201

XLON

255

1308

08/01/2026 09:39:15

1366925565247202

XLON

282

1308

08/01/2026 09:39:15

1366925565247203

XLON

213

1306

08/01/2026 09:39:23

1366925565247223

XLON

1

1304

08/01/2026 09:43:25

1366925565247748

XLON

37

1304

08/01/2026 09:43:25

1366925565247749

XLON

1

1304

08/01/2026 09:43:30

1366925565247755

XLON

32

1304

08/01/2026 09:43:30

1366925565247756

XLON

108

1304

08/01/2026 09:43:30

1366925565247757

XLON

11

1304

08/01/2026 09:43:31

1366925565247758

XLON

66

1310

08/01/2026 09:54:04

1366925565248862

XLON

745

1308

08/01/2026 10:22:57

1366925565251594

XLON

507

1306

08/01/2026 10:23:01

1366925565251612

XLON

304

1306

08/01/2026 10:23:06

1366925565251622

XLON

356

1308

08/01/2026 10:28:24

1366925565252068

XLON

103

1308

08/01/2026 10:28:24

1366925565252073

XLON

8

1308

08/01/2026 10:28:24

1366925565252074

XLON

253

1308

08/01/2026 10:30:46

1366925565252215

XLON

138

1306

08/01/2026 10:35:56

1366925565252647

XLON

468

1312

08/01/2026 11:08:50

1366925565254720

XLON

422

1312

08/01/2026 11:08:50

1366925565254721

XLON

456

1310

08/01/2026 11:17:13

1366925565255297

XLON

512

1310

08/01/2026 11:32:38

1366925565256171

XLON

195

1308

08/01/2026 11:32:50

1366925565256183

XLON

140

1306

08/01/2026 11:37:25

1366925565256357

XLON

3

1304

08/01/2026 11:45:29

1366925565256831

XLON

905

1304

08/01/2026 11:45:29

1366925565256832

XLON

905

1302

08/01/2026 11:47:38

1366925565256965

XLON

592

1302

08/01/2026 11:47:38

1366925565256967

XLON

316

1302

08/01/2026 11:47:38

1366925565256968

XLON

905

1300

08/01/2026 11:49:53

1366925565257082

XLON

899

1300

08/01/2026 11:49:53

1366925565257087

XLON

766

1300

08/01/2026 11:55:17

1366925565257496

XLON

98

1300

08/01/2026 11:55:17

1366925565257497

XLON

71

1298

08/01/2026 11:58:17

1366925565257613

XLON

454

1306

08/01/2026 15:26:45

1366925565288010

XLON

444

1306

08/01/2026 15:26:45

1366925565288013

XLON

 

 

 

Contacts

CVS Group plc via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR) cvsg@camarco.co.uk

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUPURWGUPQPUR
Date   Source Headline
1st Jul 20264:53 pmRNSStandard form for notification of major holdings
30th Jun 20264:21 pmRNSStandard form for notification of major holdings
30th Jun 202610:59 amRNSStandard form for notification of major holdings
30th Jun 20267:00 amRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20269:48 amRNSStandard form for notification of major holdings
15th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 202611:08 amRNSHolding(s) in Company
12th Jun 202610:06 amRNSHolding(s) in Company
8th Jun 20262:43 pmRNSStandard form for notification of major holdings
8th Jun 20262:41 pmRNSUpdated: Transaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSPDMR Dealing
26th May 20267:02 amRNSChanges to NEDs' Responsibilities
26th May 20267:01 amRNSCommencement of Share Buyback Programme
26th May 20267:00 amRNSRefinancing, Launch of SBB and Acquisition
8th May 20263:55 pmRNSStandard form for notification of major holdings
30th Apr 20267:00 amRNSTotal Voting Rights
21st Apr 202612:46 pmRNSNon-Executive Director Appointment
20th Apr 20264:45 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSCEO retirement
25th Mar 20267:00 amRNSNon-Executive Director Changes
24th Mar 20267:13 amRNSResponse to CMA Summary Final Decision Report
27th Feb 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSTotal Voting Rights
29th Jan 20262:02 pmRNSStandard form for notification of major holdings
29th Jan 20268:00 amRNSReadmission - CVS Group Plc
29th Jan 20267:00 amRNSAdmission to Trading on the Main Market of the LSE
28th Jan 20267:08 amRNSResponse to DEFRA consultation
27th Jan 20262:31 pmRNSStandard form for notification of major holdings
23rd Jan 202612:19 pmRNSPublication of Prospectus and Trading Update
23rd Jan 20267:00 amRNSProgramme completion and transaction in own shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20269:51 amRNSStandard form for notification of major holdings
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:24 pmRNSStandard form for notification of major holdings
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSBlock Listing Interim Review
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.